The drugmaker#39;s bottomline for the Oct-Dec period fell 72 percent on year primarily due to a high base in the corresponding quarter last year.
The drugmaker#39;s bottomline for the Oct-Dec period fell 72 percent on year primarily due to a high base in the corresponding quarter last year. The drugmaker#39;s bottomline for the Oct-Dec period fell 72 percent on year primarily due to a high base in the corresponding quarter last year. Moneycontrol Latest News Read More
हिन्दी 
English